[1]Moller S, Wiinberg N, Henriksen JH.Noninvasive 24 hourambulatory arterial blood pressure monitoring in cirrhosis[J].Hepatology, 1995, 22 (1) :88-95.
|
[2] 李磊, 平春霞, 张斌, 等.肝硬化门脉高压患者心脏泵功能减退[J].中华肝脏病杂志, 2009, 17 (6) :467-468.
|
[3]中华医学会传染病与寄生虫、肝病分会.病毒性肝炎防治方案[J].中华肝脏病杂志, 2000, 8 (6) :324-329.
|
[4] 中华医学会消化内镜分会食管胃静脉曲张学组.消化道静脉曲张及出血的内镜诊断和治疗规范试行方案 (2009年) [J].中华消化内镜杂志, 2010, 27 (1) :1-4.
|
[5]Marik PE, Baram M.Nonivasive hemodynamic monitoring inthe intensive care unit[J].Crit Care Clin, 2007, 23 (3) :383-400.
|
[6]Sanyal AJ, Bosch J, Blei A, et al.Portal hypertension and itscomplications[J].Gastroenterol, 2008, 134 (6) :1715-1728.
|
[7]La Villa G, Gentilini P.Hemodynamic alterations in liver cir-rhosis[J].Mol Aspects Med, 2008, 29 (1-2) :112-118.
|
[8]Zipprich A.Hemodynamics in the isolated cirrhotic liver[J].J Clin Gastroenterol, 2007, 41 (Suppl 3) :S254-258.
|
[9]Moller S, Henriksen JH.Cardiovascular complications of cir-rhosis[J].Gut, 2008, 57 (2) :268-278.
|
[10]Liu H, Lee SS.Nuclear factor-kappaB inhibition improvesmyocardial contractility in rats with cirrhotic cardiomyopathy[J].Liver Int, 2008, 28 (5) :640-648.
|
[11]Krag A, Bendtsen F, Henriksen JH, et al.Low cardiac out-put predicts development of hepatorenal syndrome and sur-vival in patients with cirrhosis and ascites[J].Gut, 2010, 59 (1) :105-110.
|